EN
CN EN
SUYA-FIX
Human Coagulation Factor IX

Used for bleeding treatment in patients aged 12 and above with factor Ⅸ deficiency (hemophilia B).
Name
Human Coagulation Factor IX
Category
Hematology, Critical Illness
Use within
24 months
Specifications
500IU/vial, 10ml after redissolution
Approval number
NMPA Approval No. S20233098
Indications
Used for bleeding treatment in patients aged 12 and above with factor Ⅸ deficiency (hemophilia B).